img

Global Pharmaceutical Intermediate CDMO Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Pharmaceutical Intermediate CDMO Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Pharmaceutical Intermediate CDMO Market
Global Pharmaceutical Intermediate CDMO market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Pharmaceutical Intermediate CDMO industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Pharmaceutical Intermediate CDMO key companies include Cambrex, WR Grace, Esteve Química, AGC Pharma Chemicals, Evonik, CordenPharma, Otsuka Chemical, Wavelength and KBI Biopharma, etc. Cambrex, WR Grace, Esteve Química are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Pharmaceutical Intermediate CDMO were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Pharmaceutical Intermediate CDMO market and estimated to attract more attentions from industry insiders and investors.
Pharmaceutical Intermediate CDMO can be divided into Small Molecule Cdmo and Macromolecular Cdmo, etc. Small Molecule Cdmo is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Pharmaceutical Intermediate CDMO is widely used in various fields, such as Pharmaceutical Company, Biotechnology Company and Others,, etc. Pharmaceutical Company provides greatest supports to the Pharmaceutical Intermediate CDMO industry development. In 2022, global % revenue of Pharmaceutical Intermediate CDMO went into Pharmaceutical Company filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Pharmaceutical Intermediate CDMO market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Pharmaceutical Intermediate CDMO market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Cambrex
WR Grace
Esteve Química
AGC Pharma Chemicals
Evonik
CordenPharma
Otsuka Chemical
Wavelength
KBI Biopharma
Chengda Pharmaceuticals
Apeloa Pharmaceutical
Xi'an Manareco New Materials
Shenzhen Sungening Bio-technology
Chengdu D-innovation Pharmaceutical
Huateng Pharma
Segment by Type
Small Molecule Cdmo
Macromolecular Cdmo

Segment by Application


Pharmaceutical Company
Biotechnology Company
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Pharmaceutical Intermediate CDMO introduction, etc. Pharmaceutical Intermediate CDMO Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Pharmaceutical Intermediate CDMO
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Intermediate CDMO Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Small Molecule Cdmo
1.2.3 Macromolecular Cdmo
1.3 Market by Application
1.3.1 Global Pharmaceutical Intermediate CDMO Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Pharmaceutical Company
1.3.3 Biotechnology Company
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Intermediate CDMO Market Perspective (2018-2033)
2.2 Global Pharmaceutical Intermediate CDMO Growth Trends by Region
2.2.1 Pharmaceutical Intermediate CDMO Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Pharmaceutical Intermediate CDMO Historic Market Size by Region (2018-2023)
2.2.3 Pharmaceutical Intermediate CDMO Forecasted Market Size by Region (2024-2033)
2.3 Pharmaceutical Intermediate CDMO Market Dynamics
2.3.1 Pharmaceutical Intermediate CDMO Industry Trends
2.3.2 Pharmaceutical Intermediate CDMO Market Drivers
2.3.3 Pharmaceutical Intermediate CDMO Market Challenges
2.3.4 Pharmaceutical Intermediate CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Pharmaceutical Intermediate CDMO by Players
3.1.1 Global Pharmaceutical Intermediate CDMO Revenue by Players (2018-2023)
3.1.2 Global Pharmaceutical Intermediate CDMO Revenue Market Share by Players (2018-2023)
3.2 Global Pharmaceutical Intermediate CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Pharmaceutical Intermediate CDMO, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Pharmaceutical Intermediate CDMO Market Concentration Ratio
3.4.1 Global Pharmaceutical Intermediate CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Intermediate CDMO Revenue in 2022
3.5 Global Key Players of Pharmaceutical Intermediate CDMO Head office and Area Served
3.6 Global Key Players of Pharmaceutical Intermediate CDMO, Product and Application
3.7 Global Key Players of Pharmaceutical Intermediate CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Intermediate CDMO Breakdown Data by Type
4.1 Global Pharmaceutical Intermediate CDMO Historic Market Size by Type (2018-2023)
4.2 Global Pharmaceutical Intermediate CDMO Forecasted Market Size by Type (2024-2033)
5 Pharmaceutical Intermediate CDMO Breakdown Data by Application
5.1 Global Pharmaceutical Intermediate CDMO Historic Market Size by Application (2018-2023)
5.2 Global Pharmaceutical Intermediate CDMO Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Pharmaceutical Intermediate CDMO Market Size (2018-2033)
6.2 North America Pharmaceutical Intermediate CDMO Market Size by Type
6.2.1 North America Pharmaceutical Intermediate CDMO Market Size by Type (2018-2023)
6.2.2 North America Pharmaceutical Intermediate CDMO Market Size by Type (2024-2033)
6.2.3 North America Pharmaceutical Intermediate CDMO Market Share by Type (2018-2033)
6.3 North America Pharmaceutical Intermediate CDMO Market Size by Application
6.3.1 North America Pharmaceutical Intermediate CDMO Market Size by Application (2018-2023)
6.3.2 North America Pharmaceutical Intermediate CDMO Market Size by Application (2024-2033)
6.3.3 North America Pharmaceutical Intermediate CDMO Market Share by Application (2018-2033)
6.4 North America Pharmaceutical Intermediate CDMO Market Size by Country
6.4.1 North America Pharmaceutical Intermediate CDMO Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Pharmaceutical Intermediate CDMO Market Size by Country (2018-2023)
6.4.3 North America Pharmaceutical Intermediate CDMO Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Pharmaceutical Intermediate CDMO Market Size (2018-2033)
7.2 Europe Pharmaceutical Intermediate CDMO Market Size by Type
7.2.1 Europe Pharmaceutical Intermediate CDMO Market Size by Type (2018-2023)
7.2.2 Europe Pharmaceutical Intermediate CDMO Market Size by Type (2024-2033)
7.2.3 Europe Pharmaceutical Intermediate CDMO Market Share by Type (2018-2033)
7.3 Europe Pharmaceutical Intermediate CDMO Market Size by Application
7.3.1 Europe Pharmaceutical Intermediate CDMO Market Size by Application (2018-2023)
7.3.2 Europe Pharmaceutical Intermediate CDMO Market Size by Application (2024-2033)
7.3.3 Europe Pharmaceutical Intermediate CDMO Market Share by Application (2018-2033)
7.4 Europe Pharmaceutical Intermediate CDMO Market Size by Country
7.4.1 Europe Pharmaceutical Intermediate CDMO Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Pharmaceutical Intermediate CDMO Market Size by Country (2018-2023)
7.4.3 Europe Pharmaceutical Intermediate CDMO Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Pharmaceutical Intermediate CDMO Market Size (2018-2033)
8.2 China Pharmaceutical Intermediate CDMO Market Size by Type
8.2.1 China Pharmaceutical Intermediate CDMO Market Size by Type (2018-2023)
8.2.2 China Pharmaceutical Intermediate CDMO Market Size by Type (2024-2033)
8.2.3 China Pharmaceutical Intermediate CDMO Market Share by Type (2018-2033)
8.3 China Pharmaceutical Intermediate CDMO Market Size by Application
8.3.1 China Pharmaceutical Intermediate CDMO Market Size by Application (2018-2023)
8.3.2 China Pharmaceutical Intermediate CDMO Market Size by Application (2024-2033)
8.3.3 China Pharmaceutical Intermediate CDMO Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Pharmaceutical Intermediate CDMO Market Size (2018-2033)
9.2 Asia Pharmaceutical Intermediate CDMO Market Size by Type
9.2.1 Asia Pharmaceutical Intermediate CDMO Market Size by Type (2018-2023)
9.2.2 Asia Pharmaceutical Intermediate CDMO Market Size by Type (2024-2033)
9.2.3 Asia Pharmaceutical Intermediate CDMO Market Share by Type (2018-2033)
9.3 Asia Pharmaceutical Intermediate CDMO Market Size by Application
9.3.1 Asia Pharmaceutical Intermediate CDMO Market Size by Application (2018-2023)
9.3.2 Asia Pharmaceutical Intermediate CDMO Market Size by Application (2024-2033)
9.3.3 Asia Pharmaceutical Intermediate CDMO Market Share by Application (2018-2033)
9.4 Asia Pharmaceutical Intermediate CDMO Market Size by Region
9.4.1 Asia Pharmaceutical Intermediate CDMO Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Pharmaceutical Intermediate CDMO Market Size by Region (2018-2023)
9.4.3 Asia Pharmaceutical Intermediate CDMO Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Pharmaceutical Intermediate CDMO Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Pharmaceutical Intermediate CDMO Market Size by Type
10.2.1 Middle East, Africa, and Latin America Pharmaceutical Intermediate CDMO Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Pharmaceutical Intermediate CDMO Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Pharmaceutical Intermediate CDMO Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Pharmaceutical Intermediate CDMO Market Size by Application
10.3.1 Middle East, Africa, and Latin America Pharmaceutical Intermediate CDMO Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Pharmaceutical Intermediate CDMO Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Pharmaceutical Intermediate CDMO Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Pharmaceutical Intermediate CDMO Market Size by Country
10.4.1 Middle East, Africa, and Latin America Pharmaceutical Intermediate CDMO Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Pharmaceutical Intermediate CDMO Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Pharmaceutical Intermediate CDMO Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Cambrex
11.1.1 Cambrex Company Details
11.1.2 Cambrex Business Overview
11.1.3 Cambrex Pharmaceutical Intermediate CDMO Introduction
11.1.4 Cambrex Revenue in Pharmaceutical Intermediate CDMO Business (2018-2023)
11.1.5 Cambrex Recent Developments
11.2 WR Grace
11.2.1 WR Grace Company Details
11.2.2 WR Grace Business Overview
11.2.3 WR Grace Pharmaceutical Intermediate CDMO Introduction
11.2.4 WR Grace Revenue in Pharmaceutical Intermediate CDMO Business (2018-2023)
11.2.5 WR Grace Recent Developments
11.3 Esteve Química
11.3.1 Esteve Química Company Details
11.3.2 Esteve Química Business Overview
11.3.3 Esteve Química Pharmaceutical Intermediate CDMO Introduction
11.3.4 Esteve Química Revenue in Pharmaceutical Intermediate CDMO Business (2018-2023)
11.3.5 Esteve Química Recent Developments
11.4 AGC Pharma Chemicals
11.4.1 AGC Pharma Chemicals Company Details
11.4.2 AGC Pharma Chemicals Business Overview
11.4.3 AGC Pharma Chemicals Pharmaceutical Intermediate CDMO Introduction
11.4.4 AGC Pharma Chemicals Revenue in Pharmaceutical Intermediate CDMO Business (2018-2023)
11.4.5 AGC Pharma Chemicals Recent Developments
11.5 Evonik
11.5.1 Evonik Company Details
11.5.2 Evonik Business Overview
11.5.3 Evonik Pharmaceutical Intermediate CDMO Introduction
11.5.4 Evonik Revenue in Pharmaceutical Intermediate CDMO Business (2018-2023)
11.5.5 Evonik Recent Developments
11.6 CordenPharma
11.6.1 CordenPharma Company Details
11.6.2 CordenPharma Business Overview
11.6.3 CordenPharma Pharmaceutical Intermediate CDMO Introduction
11.6.4 CordenPharma Revenue in Pharmaceutical Intermediate CDMO Business (2018-2023)
11.6.5 CordenPharma Recent Developments
11.7 Otsuka Chemical
11.7.1 Otsuka Chemical Company Details
11.7.2 Otsuka Chemical Business Overview
11.7.3 Otsuka Chemical Pharmaceutical Intermediate CDMO Introduction
11.7.4 Otsuka Chemical Revenue in Pharmaceutical Intermediate CDMO Business (2018-2023)
11.7.5 Otsuka Chemical Recent Developments
11.8 Wavelength
11.8.1 Wavelength Company Details
11.8.2 Wavelength Business Overview
11.8.3 Wavelength Pharmaceutical Intermediate CDMO Introduction
11.8.4 Wavelength Revenue in Pharmaceutical Intermediate CDMO Business (2018-2023)
11.8.5 Wavelength Recent Developments
11.9 KBI Biopharma
11.9.1 KBI Biopharma Company Details
11.9.2 KBI Biopharma Business Overview
11.9.3 KBI Biopharma Pharmaceutical Intermediate CDMO Introduction
11.9.4 KBI Biopharma Revenue in Pharmaceutical Intermediate CDMO Business (2018-2023)
11.9.5 KBI Biopharma Recent Developments
11.10 Chengda Pharmaceuticals
11.10.1 Chengda Pharmaceuticals Company Details
11.10.2 Chengda Pharmaceuticals Business Overview
11.10.3 Chengda Pharmaceuticals Pharmaceutical Intermediate CDMO Introduction
11.10.4 Chengda Pharmaceuticals Revenue in Pharmaceutical Intermediate CDMO Business (2018-2023)
11.10.5 Chengda Pharmaceuticals Recent Developments
11.11 Apeloa Pharmaceutical
11.11.1 Apeloa Pharmaceutical Company Details
11.11.2 Apeloa Pharmaceutical Business Overview
11.11.3 Apeloa Pharmaceutical Pharmaceutical Intermediate CDMO Introduction
11.11.4 Apeloa Pharmaceutical Revenue in Pharmaceutical Intermediate CDMO Business (2018-2023)
11.11.5 Apeloa Pharmaceutical Recent Developments
11.12 Xi'an Manareco New Materials
11.12.1 Xi'an Manareco New Materials Company Details
11.12.2 Xi'an Manareco New Materials Business Overview
11.12.3 Xi'an Manareco New Materials Pharmaceutical Intermediate CDMO Introduction
11.12.4 Xi'an Manareco New Materials Revenue in Pharmaceutical Intermediate CDMO Business (2018-2023)
11.12.5 Xi'an Manareco New Materials Recent Developments
11.13 Shenzhen Sungening Bio-technology
11.13.1 Shenzhen Sungening Bio-technology Company Details
11.13.2 Shenzhen Sungening Bio-technology Business Overview
11.13.3 Shenzhen Sungening Bio-technology Pharmaceutical Intermediate CDMO Introduction
11.13.4 Shenzhen Sungening Bio-technology Revenue in Pharmaceutical Intermediate CDMO Business (2018-2023)
11.13.5 Shenzhen Sungening Bio-technology Recent Developments
11.14 Chengdu D-innovation Pharmaceutical
11.14.1 Chengdu D-innovation Pharmaceutical Company Details
11.14.2 Chengdu D-innovation Pharmaceutical Business Overview
11.14.3 Chengdu D-innovation Pharmaceutical Pharmaceutical Intermediate CDMO Introduction
11.14.4 Chengdu D-innovation Pharmaceutical Revenue in Pharmaceutical Intermediate CDMO Business (2018-2023)
11.14.5 Chengdu D-innovation Pharmaceutical Recent Developments
11.15 Huateng Pharma
11.15.1 Huateng Pharma Company Details
11.15.2 Huateng Pharma Business Overview
11.15.3 Huateng Pharma Pharmaceutical Intermediate CDMO Introduction
11.15.4 Huateng Pharma Revenue in Pharmaceutical Intermediate CDMO Business (2018-2023)
11.15.5 Huateng Pharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Pharmaceutical Intermediate CDMO Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Small Molecule Cdmo
Table 3. Key Players of Macromolecular Cdmo
Table 4. Global Pharmaceutical Intermediate CDMO Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global Pharmaceutical Intermediate CDMO Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Pharmaceutical Intermediate CDMO Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Pharmaceutical Intermediate CDMO Market Share by Region (2018-2023)
Table 8. Global Pharmaceutical Intermediate CDMO Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Pharmaceutical Intermediate CDMO Market Share by Region (2024-2033)
Table 10. Pharmaceutical Intermediate CDMO Market Trends
Table 11. Pharmaceutical Intermediate CDMO Market Drivers
Table 12. Pharmaceutical Intermediate CDMO Market Challenges
Table 13. Pharmaceutical Intermediate CDMO Market Restraints
Table 14. Global Pharmaceutical Intermediate CDMO Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Pharmaceutical Intermediate CDMO Revenue Share by Players (2018-2023)
Table 16. Global Top Pharmaceutical Intermediate CDMO by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Intermediate CDMO as of 2022)
Table 17. Global Pharmaceutical Intermediate CDMO Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Pharmaceutical Intermediate CDMO Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Pharmaceutical Intermediate CDMO, Headquarters and Area Served
Table 20. Global Key Players of Pharmaceutical Intermediate CDMO, Product and Application
Table 21. Global Key Players of Pharmaceutical Intermediate CDMO, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Pharmaceutical Intermediate CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Pharmaceutical Intermediate CDMO Revenue Market Share by Type (2018-2023)
Table 25. Global Pharmaceutical Intermediate CDMO Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Pharmaceutical Intermediate CDMO Revenue Market Share by Type (2024-2033)
Table 27. Global Pharmaceutical Intermediate CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Pharmaceutical Intermediate CDMO Revenue Share by Application (2018-2023)
Table 29. Global Pharmaceutical Intermediate CDMO Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Pharmaceutical Intermediate CDMO Revenue Share by Application (2024-2033)
Table 31. North America Pharmaceutical Intermediate CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Pharmaceutical Intermediate CDMO Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America Pharmaceutical Intermediate CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Pharmaceutical Intermediate CDMO Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America Pharmaceutical Intermediate CDMO Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Pharmaceutical Intermediate CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Pharmaceutical Intermediate CDMO Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Pharmaceutical Intermediate CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Pharmaceutical Intermediate CDMO Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe Pharmaceutical Intermediate CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Pharmaceutical Intermediate CDMO Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe Pharmaceutical Intermediate CDMO Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Pharmaceutical Intermediate CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Pharmaceutical Intermediate CDMO Market Size by Country (2024-2033) & (US$ Million)
Table 45. China Pharmaceutical Intermediate CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Pharmaceutical Intermediate CDMO Market Size by Type (2024-2033) & (US$ Million)
Table 47. China Pharmaceutical Intermediate CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Pharmaceutical Intermediate CDMO Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia Pharmaceutical Intermediate CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Pharmaceutical Intermediate CDMO Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia Pharmaceutical Intermediate CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Pharmaceutical Intermediate CDMO Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Pharmaceutical Intermediate CDMO Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia Pharmaceutical Intermediate CDMO Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Pharmaceutical Intermediate CDMO Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Pharmaceutical Intermediate CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Pharmaceutical Intermediate CDMO Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Pharmaceutical Intermediate CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Pharmaceutical Intermediate CDMO Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Pharmaceutical Intermediate CDMO Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America Pharmaceutical Intermediate CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Pharmaceutical Intermediate CDMO Market Size by Country (2024-2033) & (US$ Million)
Table 63. Cambrex Company Details
Table 64. Cambrex Business Overview
Table 65. Cambrex Pharmaceutical Intermediate CDMO Product
Table 66. Cambrex Revenue in Pharmaceutical Intermediate CDMO Business (2018-2023) & (US$ Million)
Table 67. Cambrex Recent Developments
Table 68. WR Grace Company Details
Table 69. WR Grace Business Overview
Table 70. WR Grace Pharmaceutical Intermediate CDMO Product
Table 71. WR Grace Revenue in Pharmaceutical Intermediate CDMO Business (2018-2023) & (US$ Million)
Table 72. WR Grace Recent Developments
Table 73. Esteve Química Company Details
Table 74. Esteve Química Business Overview
Table 75. Esteve Química Pharmaceutical Intermediate CDMO Product
Table 76. Esteve Química Revenue in Pharmaceutical Intermediate CDMO Business (2018-2023) & (US$ Million)
Table 77. Esteve Química Recent Developments
Table 78. AGC Pharma Chemicals Company Details
Table 79. AGC Pharma Chemicals Business Overview
Table 80. AGC Pharma Chemicals Pharmaceutical Intermediate CDMO Product
Table 81. AGC Pharma Chemicals Revenue in Pharmaceutical Intermediate CDMO Business (2018-2023) & (US$ Million)
Table 82. AGC Pharma Chemicals Recent Developments
Table 83. Evonik Company Details
Table 84. Evonik Business Overview
Table 85. Evonik Pharmaceutical Intermediate CDMO Product
Table 86. Evonik Revenue in Pharmaceutical Intermediate CDMO Business (2018-2023) & (US$ Million)
Table 87. Evonik Recent Developments
Table 88. CordenPharma Company Details
Table 89. CordenPharma Business Overview
Table 90. CordenPharma Pharmaceutical Intermediate CDMO Product
Table 91. CordenPharma Revenue in Pharmaceutical Intermediate CDMO Business (2018-2023) & (US$ Million)
Table 92. CordenPharma Recent Developments
Table 93. Otsuka Chemical Company Details
Table 94. Otsuka Chemical Business Overview
Table 95. Otsuka Chemical Pharmaceutical Intermediate CDMO Product
Table 96. Otsuka Chemical Revenue in Pharmaceutical Intermediate CDMO Business (2018-2023) & (US$ Million)
Table 97. Otsuka Chemical Recent Developments
Table 98. Wavelength Company Details
Table 99. Wavelength Business Overview
Table 100. Wavelength Pharmaceutical Intermediate CDMO Product
Table 101. Wavelength Revenue in Pharmaceutical Intermediate CDMO Business (2018-2023) & (US$ Million)
Table 102. Wavelength Recent Developments
Table 103. KBI Biopharma Company Details
Table 104. KBI Biopharma Business Overview
Table 105. KBI Biopharma Pharmaceutical Intermediate CDMO Product
Table 106. KBI Biopharma Revenue in Pharmaceutical Intermediate CDMO Business (2018-2023) & (US$ Million)
Table 107. KBI Biopharma Recent Developments
Table 108. Chengda Pharmaceuticals Company Details
Table 109. Chengda Pharmaceuticals Business Overview
Table 110. Chengda Pharmaceuticals Pharmaceutical Intermediate CDMO Product
Table 111. Chengda Pharmaceuticals Revenue in Pharmaceutical Intermediate CDMO Business (2018-2023) & (US$ Million)
Table 112. Chengda Pharmaceuticals Recent Developments
Table 113. Apeloa Pharmaceutical Company Details
Table 114. Apeloa Pharmaceutical Business Overview
Table 115. Apeloa Pharmaceutical Pharmaceutical Intermediate CDMO Product
Table 116. Apeloa Pharmaceutical Revenue in Pharmaceutical Intermediate CDMO Business (2018-2023) & (US$ Million)
Table 117. Apeloa Pharmaceutical Recent Developments
Table 118. Xi'an Manareco New Materials Company Details
Table 119. Xi'an Manareco New Materials Business Overview
Table 120. Xi'an Manareco New Materials Pharmaceutical Intermediate CDMO Product
Table 121. Xi'an Manareco New Materials Revenue in Pharmaceutical Intermediate CDMO Business (2018-2023) & (US$ Million)
Table 122. Xi'an Manareco New Materials Recent Developments
Table 123. Shenzhen Sungening Bio-technology Company Details
Table 124. Shenzhen Sungening Bio-technology Business Overview
Table 125. Shenzhen Sungening Bio-technology Pharmaceutical Intermediate CDMO Product
Table 126. Shenzhen Sungening Bio-technology Revenue in Pharmaceutical Intermediate CDMO Business (2018-2023) & (US$ Million)
Table 127. Shenzhen Sungening Bio-technology Recent Developments
Table 128. Chengdu D-innovation Pharmaceutical Company Details
Table 129. Chengdu D-innovation Pharmaceutical Business Overview
Table 130. Chengdu D-innovation Pharmaceutical Pharmaceutical Intermediate CDMO Product
Table 131. Chengdu D-innovation Pharmaceutical Revenue in Pharmaceutical Intermediate CDMO Business (2018-2023) & (US$ Million)
Table 132. Chengdu D-innovation Pharmaceutical Recent Developments
Table 133. Huateng Pharma Company Details
Table 134. Huateng Pharma Business Overview
Table 135. Huateng Pharma Pharmaceutical Intermediate CDMO Product
Table 136. Huateng Pharma Revenue in Pharmaceutical Intermediate CDMO Business (2018-2023) & (US$ Million)
Table 137. Huateng Pharma Recent Developments
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmaceutical Intermediate CDMO Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Pharmaceutical Intermediate CDMO Market Share by Type: 2022 VS 2033
Figure 3. Small Molecule Cdmo Features
Figure 4. Macromolecular Cdmo Features
Figure 5. Global Pharmaceutical Intermediate CDMO Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global Pharmaceutical Intermediate CDMO Market Share by Application: 2022 VS 2033
Figure 7. Pharmaceutical Company Case Studies
Figure 8. Biotechnology Company Case Studies
Figure 9. Others Case Studies
Figure 10. Pharmaceutical Intermediate CDMO Report Years Considered
Figure 11. Global Pharmaceutical Intermediate CDMO Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Pharmaceutical Intermediate CDMO Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Pharmaceutical Intermediate CDMO Market Share by Region: 2022 VS 2033
Figure 14. Global Pharmaceutical Intermediate CDMO Market Share by Players in 2022
Figure 15. Global Top Pharmaceutical Intermediate CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Intermediate CDMO as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Pharmaceutical Intermediate CDMO Revenue in 2022
Figure 17. North America Pharmaceutical Intermediate CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Pharmaceutical Intermediate CDMO Market Share by Type (2018-2033)
Figure 19. North America Pharmaceutical Intermediate CDMO Market Share by Application (2018-2033)
Figure 20. North America Pharmaceutical Intermediate CDMO Market Share by Country (2018-2033)
Figure 21. United States Pharmaceutical Intermediate CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Pharmaceutical Intermediate CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Pharmaceutical Intermediate CDMO Market Size YoY (2018-2033) & (US$ Million)
Figure 24. Europe Pharmaceutical Intermediate CDMO Market Share by Type (2018-2033)
Figure 25. Europe Pharmaceutical Intermediate CDMO Market Share by Application (2018-2033)
Figure 26. Europe Pharmaceutical Intermediate CDMO Market Share by Country (2018-2033)
Figure 27. Germany Pharmaceutical Intermediate CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Pharmaceutical Intermediate CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Pharmaceutical Intermediate CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Pharmaceutical Intermediate CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Pharmaceutical Intermediate CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Pharmaceutical Intermediate CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. China Pharmaceutical Intermediate CDMO Market Size YoY (2018-2033) & (US$ Million)
Figure 34. China Pharmaceutical Intermediate CDMO Market Share by Type (2018-2033)
Figure 35. China Pharmaceutical Intermediate CDMO Market Share by Application (2018-2033)
Figure 36. Asia Pharmaceutical Intermediate CDMO Market Size YoY (2018-2033) & (US$ Million)
Figure 37. Asia Pharmaceutical Intermediate CDMO Market Share by Type (2018-2033)
Figure 38. Asia Pharmaceutical Intermediate CDMO Market Share by Application (2018-2033)
Figure 39. Asia Pharmaceutical Intermediate CDMO Market Share by Region (2018-2033)
Figure 40. Japan Pharmaceutical Intermediate CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. South Korea Pharmaceutical Intermediate CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. China Taiwan Pharmaceutical Intermediate CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Southeast Asia Pharmaceutical Intermediate CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. India Pharmaceutical Intermediate CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Australia Pharmaceutical Intermediate CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Pharmaceutical Intermediate CDMO Market Size YoY (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Pharmaceutical Intermediate CDMO Market Share by Type (2018-2033)
Figure 48. Middle East, Africa, and Latin America Pharmaceutical Intermediate CDMO Market Share by Application (2018-2033)
Figure 49. Middle East, Africa, and Latin America Pharmaceutical Intermediate CDMO Market Share by Country (2018-2033)
Figure 50. Brazil Pharmaceutical Intermediate CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Mexico Pharmaceutical Intermediate CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Turkey Pharmaceutical Intermediate CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Pharmaceutical Intermediate CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Israel Pharmaceutical Intermediate CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. GCC Countries Pharmaceutical Intermediate CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Cambrex Revenue Growth Rate in Pharmaceutical Intermediate CDMO Business (2018-2023)
Figure 57. WR Grace Revenue Growth Rate in Pharmaceutical Intermediate CDMO Business (2018-2023)
Figure 58. Esteve Química Revenue Growth Rate in Pharmaceutical Intermediate CDMO Business (2018-2023)
Figure 59. AGC Pharma Chemicals Revenue Growth Rate in Pharmaceutical Intermediate CDMO Business (2018-2023)
Figure 60. Evonik Revenue Growth Rate in Pharmaceutical Intermediate CDMO Business (2018-2023)
Figure 61. CordenPharma Revenue Growth Rate in Pharmaceutical Intermediate CDMO Business (2018-2023)
Figure 62. Otsuka Chemical Revenue Growth Rate in Pharmaceutical Intermediate CDMO Business (2018-2023)
Figure 63. Wavelength Revenue Growth Rate in Pharmaceutical Intermediate CDMO Business (2018-2023)
Figure 64. KBI Biopharma Revenue Growth Rate in Pharmaceutical Intermediate CDMO Business (2018-2023)
Figure 65. Chengda Pharmaceuticals Revenue Growth Rate in Pharmaceutical Intermediate CDMO Business (2018-2023)
Figure 66. Apeloa Pharmaceutical Revenue Growth Rate in Pharmaceutical Intermediate CDMO Business (2018-2023)
Figure 67. Xi'an Manareco New Materials Revenue Growth Rate in Pharmaceutical Intermediate CDMO Business (2018-2023)
Figure 68. Shenzhen Sungening Bio-technology Revenue Growth Rate in Pharmaceutical Intermediate CDMO Business (2018-2023)
Figure 69. Chengdu D-innovation Pharmaceutical Revenue Growth Rate in Pharmaceutical Intermediate CDMO Business (2018-2023)
Figure 70. Huateng Pharma Revenue Growth Rate in Pharmaceutical Intermediate CDMO Business (2018-2023)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries